Racing to develop models of understanding

Accelerating the expansion of what we know about COVID-19 is critical to conquering the pandemic. The world needs faster testing, faster vaccine development, faster results — but how?

The scientific and medical research communities stand united in their steadfast efforts to find not just a vaccine, but other effective therapeutics such as antiviral drugs, peptide inhibitors, nucleoside analogues, and monoclonal antibodies. We have never been more honored to stand with them.

COVID-19 Insights: Articles

Filter by: All Research Vaccine and Drug Development Testing Development

New
Analysis of Nonmedical Masks

Research, Vaccine and Drug Development, Testing Development

Analysis of Nonmedical Masks

The use of personal protective equipment (PPE) and masks plays a critical role in prevention and control of the spread of certain respiratory infections. During the coronavirus disease (COVID-19) pandemic, the World Health Organization (WHO) released advice on the use of medical and nonmedical masks in the context of COVID-19.

Learn More
New
Paving the way out of the pandemic

Research, Vaccine and Drug Development

Paving the way out of the pandemic

Since the advent of antibiotics in the mid-19th century provided the ability to cure nearly any bacterial infection, to breakthrough vaccination approaches against diphtheria or tetanus, life-threatening diseases have shifted from bacterial and viral causes to mutated human cells, (e.g., cancer).

Learn More
New
Automation to meet the challenges of COVID-19 research

Research

Automation to meet the challenges of COVID-19 research

Clinicians and researchers face daunting questions of how to scale testing to meet demand. Research laboratories accustomed to processing a few handfuls of samples a day are now being asked to process thousands as they seek solutions to this crisis.

Learn More
New
Small yet powerful: Agilent magnetic beads

Research

Small yet powerful: Agilent magnetic beads

Agilent's legacy is largely built on the high-quality instruments we produce, which are found in labs around the world. However, the urgent need for COVID-19 testing has led to a surge in demand for one of our lesser-known products: magnetic beads.

Learn More
Trending
COVID-19 drug development: A therapeutic prescription drug overview

Vaccine and Drug Development

COVID-19 drug development: A therapeutic prescription drug overview

This overview presents a quick summary of journal articles published by various authors on small-molecule drugs that are being repurposed for COVID-19 treatment in clinical trials around the world./p>

Learn More
Trending
Inoculating your lab against future disruptions

Research, Vaccine and Drug Development, Testing Development

Inoculating your lab against future disruptions

The current pandemic is causing many in management positions to reassess their ability to respond to unforeseen changes. What can we do to prepare for whatever comes?

Learn More
Trending
COVID-19 treatment: Biotherapeutics and critical quality attribute testing

Vaccine and Drug Development

COVID-19 treatment: Biotherapeutics and critical quality attribute testing

At the time of writing, there are no vaccines or therapies available for the prevention or cure of COVID-19. Many promising avenues are being investigated, including the use of mAbs as a blocking agent to neutralize the SARS-CoV-2 virus.

Learn More
Trending
Understanding SARS-CoV-2 tools to further knowledge

Vaccine and Drug Development

Understanding SARS-CoV-2 tools to further knowledge

Structural Genomics Consortium (SGC) at Oxford University and Agilent collaborate to help develop robust and reliable methods to analyze SARS-CoV-2 spike proteins.

Learn More
COVID-19 vaccine development and separation-based analytical characterization tools

Vaccine and Drug Development

COVID-19 vaccine development and separation-based analytical characterization tools

In this article, we look at examples from each vaccine class where chromatographic separations have helped in the characterization of vaccines.

Learn More
Immune response and the COVID-19 virus

Research

Immune response and the COVID-19 virus

COVID-19 affects people of all ages, races, and genders across the globe. But the degree to which each person reacts to the intrusion of the virus has varied drastically./p>

Learn More
Supporting the rapid development of a COVID-19 antibody test

Research

Supporting the rapid development of a COVID-19 antibody test

As the response to the COVID-19 pandemic continues, officials and researchers have made a concentrated push to ramp up testing efforts. Testing helps inform us of the virus' prevalence and can give us insight into how the virus has spread and whether it has accumulated potentially relevant mutations.

Learn More
Work together, work fast

Testing Development

Work together, work fast

Collaborations within the greater virology community, including academic institutions, are accelerating the development of an antibody discovery program and get it into the clinic.

Learn More
Addressing an evolving threat with a target enrichment-based NGS approach

Research

Addressing an evolving threat with a target enrichment-based NGS approach

Identifying and linking viral mutations to observations in geographic origin, infectivity, and symptoms is helping researchers model how the virus has spread and how it may behave.

Learn More
Seeking understanding: Researchers look at the impact on immune systems

Research

Seeking understanding: Researchers look at the impact on immune systems

Tufts University Graduate School of Biomedical Sciences, using BioTek (now a part of Agilent) instruments, seeks to understand the immune system response when facing a threat like the novel coronavirus.

Learn more @ BioTek
COVID-19 insights: The need for speed

Testing Development

COVID-19 insights: The need for speed

Faster results and faster action are needed to help prevent the spread of COVID-19. See how laboratories are reducing time-to-results from days to hours.

Learn More
Better together: How working together accelerates coronavirus research

Testing Development

Better together: How working together accelerates coronavirus research

Scientists working together have already made inroads not only on vaccine development efforts, but also on the ongoing impact of the novel coronavirus.

Learn More
Customer spotlight: Live SARS-CoV-2 research – interlocking pieces working together

Research

Customer spotlight: Live SARS-CoV-2 research – interlocking pieces working together

At Boston University's National Emerging Infectious Diseases Laboratories (NEIDL), microbiologists, virologists, and other scientists have dropped their routine research projects to focus on the critical search for COVID-19 vaccines and treatments.

Learn more @ BioTek

For Research Use Only. Not for use in diagnostic procedures.

Disclaimer: Agilent products are NOT approved for COVID-19 testing, diagnosis, treatment, or mitigation. Agilent has not validated a product to detect the novel coronavirus.

欧美国产国产综合视频/一本大道香蕉综合视频/在线日本高清日本免费/飘花电影网